India is to extend its price control of essential medicines from the current 34 to at least 400 drugs, accounting for approximately 60% of the domestic pharmaceutical market.

The National Pharmaceuticals Pricing Policy 2011, proposed by the Indian Government, seeks to cover all 348 medications named in 2005’s National List of Essential Medicines, as well as other medications added earlier this year.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

The policy also promises to change the way prices are regulated, switching from a method based on market share to one based around the weighted average price of formulations belonging to the leading three brands.

Issued by the Department of Pharmaceuticals, the policy is also set to freeze prices on all drugs under price control for a further two years.

Pharmaceutical Technology Excellence Awards - Have you nominated?

Nominations are now open for the prestigious Pharmaceutical Technology Excellence Awards - one of the industry's most recognised programmes celebrating innovation, leadership, and impact. This is your chance to showcase your achievements, highlight industry advancements, and gain global recognition. Don't miss the opportunity to be honoured among the best - submit your nomination today!

Nominate Now